Cellectar Biosciences, Inc. Area of Real Estate Property
Cellectar Biosciences, Inc. (CLRB) had Area of Real Estate Property of 7.83 thousand sqft as of 2024-05-06, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:AreaOfRealEstateProperty · last filed 2026-08-13
- 2024-05-06: Area of Real Estate Property 7.83K sqft.
- 2022-12-30: Area of Real Estate Property 3.98K sqft.
| Period end | Area of Real Estate Property |
|---|---|
| 2024-05-06 | 7.83K sqft 10-Q · filed 2026-08-13 |
| 2022-12-30 | 3.98K sqft 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |